+39 02 610346.1 - info@newron.com

Latest press releases

  • 25Mar
    Newron presents encouraging detailed results of its Phase IIa study with Evenamide in patients with schizophrenia

     

  • 21Mar
    FDA APPROVES XADAGO® (SAFINAMIDE) FOR PARKINSON’S DISEASE (PD) PATIENTS

     

  • 16Mar
    Newron to Present at the 16th International Congress on Schizophrenia Research

     

  • 2Mar
    Newron announces 2016 financial results and provides outlook for 2017 Board approves agenda for AGM on March 28, 2017

     

  • 21Feb
    Newron Supports Global Rare Disease Day® 2017 and Rett Syndrome Studies

     

  • 10Jan
    Seqirus and Zambon enter into a partnership for Parkinson’s disease product in Australia and New Zealand

View All

Newron share price

Events

  • 20Sep
    Investora 2017

    Sept. 20-21, 2017 - Zurich, CH

  • 6Jun
    Jefferies 2017 Global Healthcare Conference

    June 6-9, 2017 at the Grand Hyatt in New York City

  • 22May
    Bio€quity Europe 2017

    May 22-23 - Paris, France

View Event Calendar